Under the exclusive distribution agreement, DKSH will market Wacker’s Biosolutions products-fermenter cysteine and bioengineered cyclodextrins, which are premium sugar compounds marketed under the Cavasol and Cavamax trademarks.
The new regional agreement covers the whole of South East Asia, Greater China and parts of the India subcontinent, specifically India, Bangladesh and Sri Lanka.
The cysteine is purely vegetarian without any human or animal origin, hence ideally suitable for food applications such as bakery products or flavours. Applications for cyclodextrins range from food and dietary supplement to personal care products.
Source: DKSH
.
© FoodBev Media Ltd 2024